| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | Aug 25, 2025 | PLUS THERAPEUTICS, INC. | Director | Buy | 95.0 | +110,000 | 375.08% | ✗ | $53.8K |
| May 8, 2024 | May 10, 2024 | PLUS THERAPEUTICS, INC. | Director | Buy | 90.0 | +4,167 | 16.56% | ✗ | $8.5K |
| Nov 15, 2023 | Nov 17, 2023 | PLUS THERAPEUTICS, INC. | Director | Buy | 85.0 | +2,000 | 8.64% | ✗ | $3.7K |
| Nov 10, 2023 | Nov 15, 2023 | PLUS THERAPEUTICS, INC. | Director | Buy | 90.0 | +6,000 | 34.97% | ✗ | $8.6K |
| Nov 8, 2023 | Nov 13, 2023 | PLUS THERAPEUTICS, INC. | Director | Buy | 91.3 | +9,199 | 115.55% | ✗ | $14.9K |
| Nov 6, 2023 | Nov 8, 2023 | PLUS THERAPEUTICS, INC. | Director | Buy | 91.3 | +7,395 | 1306.54% | ✗ | $11.9K |
| Dec 30, 2022 | Jan 4, 2023 | PLUS THERAPEUTICS, INC. | Director | Sell | 27.5 | -1,500 | -15.00% | ✗ | $472.1 |
| Sep 13, 2021 | Sep 15, 2021 | PLUS THERAPEUTICS, INC. | Director | Buy | 91.3 | +7,000 | 233.33% | ✗ | $13K |
| Aug 25, 2020 | Aug 26, 2020 | PLUS THERAPEUTICS, INC. | Director | Buy | 90.0 | +3,000 | 100.00% | ✗ | $7.5K |